Cerebras Systems (CBRS) Shares Drop After Q2 Miss; Price-to-Sales Ratio Highlights Growth Expectations

Author's Avatar
GuruFocus News
08/12/2026 15:57

On August 12, 2026, Cerebras Systems Inc (NASDAQ: CBRS) saw its shares decline 11.5% in after-hours trading following a second-quarter earnings report that missed analyst expectations. Despite strong revenue growth, the company’s adjusted loss per share was substantially wider than forecast, prompting investor caution.

  • Cerebras’s current Price-to-Sales (P/S) ratio stands at an elevated 291.5x, well above its historical median of approximately 238.6x and the semiconductor industry average, signaling the market’s high expectations for future revenue growth. Traditional earnings-based valuation metrics like P/E are not applicable due to the company’s unprofitable and cash-flow-negative status.
  • The company’s GF Score™ is a modest 10 out of 100, reflecting significant challenges in profitability and growth despite a solid financial strength rating.
  • Insider activity shows notable selling with no insider purchases in the past three months, totaling $20.7 million in shares sold, while one GuruFocus-tracked guru currently holds CBRS and added to their position recently, indicating mixed sentiment among informed investors.

What's Behind the News?

Cerebras Systems reported an adjusted loss of $2.98 per share for Q2 2026, far exceeding the expected loss of $0.17 per share. Revenue grew 74.3% year-over-year to $180.11 million but fell short of the $194 million analysts had anticipated. The earnings miss and wider-than-expected loss triggered the after-hours selloff. However, the company’s guidance for Q3 projects core revenue between $214 million and $216 million, which would surpass consensus estimates, suggesting management’s confidence in continued top-line expansion despite profitability challenges.

Cerebras Systems operates in the technology sector, specifically within the semiconductor industry, focusing on AI infrastructure. The company designs and manufactures the world’s largest semiconductor chips and builds AI supercomputers optimized for training and inference workloads. With a market capitalization of $58.40 billion, Cerebras is a significant player in the AI hardware space, primarily generating revenue from the U.S. market.

Is CBRS Overvalued on a Price-to-Sales Basis?

Cerebras’s current Price-to-Sales ratio of approximately 291.5x is notably higher than its historical median of 238.6x and well above typical semiconductor industry levels. This elevated P/S multiple reflects the market’s expectation that Cerebras will sustain rapid revenue growth and eventually translate that into profitability. However, investors should recognize that traditional earnings-based valuation metrics such as the Price-to-Earnings (P/E) ratio are not meaningful here, as the company remains unprofitable with negative free cash flow and operating losses.

Given these dynamics, valuation based on sales growth and market potential is more relevant than earnings multiples. The company’s GF Value™ metric currently cannot provide a reliable fair value estimate due to its unprofitable status and volatile financials, but it serves as a directional caution. For more on GF Value™, see GF Value™ for CBRS.

What Does CBRS's GF Score™ Tell Us?

The GF Score™ aggregates multiple factors including financial strength, profitability, growth, valuation, and momentum to provide a holistic view of a company’s investment quality. Cerebras’s GF Score™ of 10 out of 100 indicates significant weaknesses, particularly in profitability and growth metrics, despite moderate financial stability.

Metric Rating
GF Score™ 10/100
Financial Strength 5/10
Profitability 1/10

Cerebras’s financial strength rating of 5 out of 10 suggests a moderate balance sheet with a strong Altman Z-Score of 6.41, indicating low bankruptcy risk. However, profitability is a major concern, scoring just 1 out of 10, reflecting ongoing losses and negative margins. Growth metrics are not rated here, but revenue growth remains robust, albeit from a loss-making base. The low GF Score™ underscores the risk profile of CBRS as it invests heavily in scaling its AI hardware business.

For a detailed overview, visit the CBRS stock page.

What Are Gurus and Insiders Doing with CBRS?

GuruFocus tracks one premium guru currently holding CBRS, who has recently increased their position, signaling a degree of confidence in the company’s long-term prospects despite recent volatility. This guru ownership insight is a unique feature of GuruFocus’s data, not available through other platforms like Simply Wall St or Morningstar.

Conversely, insider activity has been negative over the past three months, with seven insider selling transactions totaling $20.7 million in shares sold and no insider buying reported. This insider selling may reflect concerns about near-term performance or personal portfolio management, adding a cautionary note for investors.

2087646763858173952.png

What This Means for Investors

Cerebras Systems remains a high-growth, high-risk technology company with a valuation that implies substantial future revenue expansion. The extremely elevated Price-to-Sales ratio highlights the market’s optimism but also the premium investors pay for growth in the absence of profitability. The low GF Score™ and significant insider selling suggest caution, as the company continues to operate with negative earnings and cash flow. Meanwhile, selective guru buying indicates some informed investors see potential value in the company’s AI infrastructure ambitions. Investors should weigh these contrasting signals carefully when considering CBRS exposure.

For ongoing updates and a comprehensive view of Cerebras Systems, visit the CBRS stock page or explore investment opportunities using the GuruFocus Stock Screener.

Frequently Asked Questions

What is CBRS's GF Score™?

CBRS’s GF Score™ is 10 out of 100, reflecting weak profitability and moderate financial strength, indicating challenges in generating earnings despite solid revenue growth.

Is CBRS overvalued or undervalued?

On a Price-to-Sales basis, CBRS is highly valued at nearly 291.5x, above its historical median and industry norms, suggesting the market expects significant future growth. Earnings-based valuation metrics like P/E are not meaningful due to the company’s ongoing losses.

What is CBRS's P/E ratio compared to historical?

CBRS does not have a meaningful P/E ratio as it remains unprofitable and cash-flow negative. Instead, its financial strength is moderate, supported by a strong Altman Z-Score indicating low bankruptcy risk.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.